- Home
- BDSX vs ENX Comparison
BDSX vs ENX Comparison
Compare BDSX & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- ENX
- Stock Information
- Founded
- BDSX 2005
- ENX 2002
- Country
- BDSX United States
- ENX United States
- Employees
- BDSX N/A
- ENX N/A
- Industry
- BDSX Precision Instruments
- ENX Finance/Investors Services
- Sector
- BDSX Health Care
- ENX Finance
- Exchange
- BDSX Nasdaq
- ENX Nasdaq
- Market Cap
- BDSX 245.3M
- ENX 178.4M
- IPO Year
- BDSX 2020
- ENX N/A
- Fundamental
- Price
- BDSX $1.63
- ENX $9.83
- Analyst Decision
- BDSX Strong Buy
- ENX
- Analyst Count
- BDSX 4
- ENX 0
- Target Price
- BDSX $3.08
- ENX N/A
- AVG Volume (30 Days)
- BDSX 255.3K
- ENX 25.4K
- Earning Date
- BDSX 11-05-2024
- ENX 01-01-0001
- Dividend Yield
- BDSX N/A
- ENX 3.94%
- EPS Growth
- BDSX N/A
- ENX N/A
- EPS
- BDSX N/A
- ENX 0.16
- Revenue
- BDSX $60,902,000.00
- ENX N/A
- Revenue This Year
- BDSX $48.06
- ENX N/A
- Revenue Next Year
- BDSX $29.97
- ENX N/A
- P/E Ratio
- BDSX N/A
- ENX $61.00
- Revenue Growth
- BDSX 46.25
- ENX N/A
- 52 Week Low
- BDSX $1.15
- ENX $7.84
- 52 Week High
- BDSX $2.21
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- BDSX 42.54
- ENX 47.05
- Support Level
- BDSX $1.59
- ENX $9.74
- Resistance Level
- BDSX $1.72
- ENX $9.83
- Average True Range (ATR)
- BDSX 0.06
- ENX 0.07
- MACD
- BDSX -0.01
- ENX -0.01
- Stochastic Oscillator
- BDSX 29.17
- ENX 34.48
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.